Revlimid and malignant neoplasm progression Patient Reports March 19, 2010

Revlimid Side Effects Report #5235028-5
Revlimid side effect was reported by a Physician from UNITED STATES on Jan 30, 2007. Female patient, 54 years of age, was diagnosed with thyroid cancer  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, thyroid cancer . Revlimid dosage: 25 MG, 1 IN 1 D, ORAL. During the same period patient was treated with PRILOSEC, ATENOLOL, SYNTHROID, ZYRTEC, ASPIRIN, LORTAB, GLIPIZIDE, DURAGESIC. Patient died on 01/28/2007.

Revlimid Side Effects Report #5452208-4
Revlimid side effect was reported by a Physician from UNITED STATES on Sept 04, 2007. Female patient, 46 years of age, weighting 231.7 lb, was diagnosed with thyroid cancer  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, metastases to bone, metastases to central nervous system, thyroid cancer metastatic. Revlimid dosage: 25 MG, 1 IN 1 D, ORAL. During the same period patient was treated with DEXAMETHASONE, DOSS, SYNTHROID, FISH OIL, ASCORBIC ACID, LEVETIRACETAM, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #6122604-0
Revlimid side effect was reported by a Consumer or non-health professional from CANADA on Mar 13, 2009. Male patient, weighting 190.0 lb, was diagnosed with t-cell lymphoma and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, muscular weakness, supraventricular tachycardia. Revlimid dosage: unknown. During the same period patient was treated with CEFUROXIME AXETIL, MORPHINE, HYDROMORPHONE, SENOKOT, COLACE, PRAVASTATIN, ACYCLOVIR, VENTOLIN DS. Patient was hospitalized. Patient died on 06/13/2008.

Revlimid Side Effects Report #5375787-4
Revlimid side effect was reported by a Physician from UNITED STATES on June 19, 2007. Male patient, 63 years of age, was diagnosed with renal cancer metastatic and was treated with Revlimid. After drug was administered, patient experienced the following side effects: anxiety , dyspnoea paroxysmal nocturnal, haemoglobin decreased, malignant neoplasm progression, metastases to bone, metastases to lung, renal cancer metastatic. Revlimid dosage: 25 MG, DAILY X 21 DAYS, ORAL. During the same period patient was treated with BLOOD TRANSFUSION. Patient died on 06/05/2007.


Revlimid Side Effects Report #5242562-0
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 06, 2007. Male patient, 52 years of age, was diagnosed with prostate cancer , prostate cancer metastatic and was treated with Revlimid. After drug was administered, patient experienced the following side effects: hypercalcaemia, malignant neoplasm progression, metastases to bone, prostate cancer metastatic. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL 10 MG, DAILY, ORAL. Patient died on 01/11/2007.

Revlimid Side Effects Report #5428651-6
Revlimid side effect was reported by a Physician from UNITED STATES on Aug 21, 2007. Male patient, 76 years of age, was diagnosed with non-hodgkin's lymphoma refractory and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, non-hodgkin's lymphoma. Revlimid dosage: 10 MG, EVERY HS, ORAL. Patient died on 07/14/2007.

Revlimid Side Effects Report #5628978-9
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 07, 2008. Male patient, 80 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Revlimid. After drug was administered, patient experienced the following side effects: lymphoma , malignant neoplasm progression. Revlimid dosage: unknown. Patient died on 02/07/2008.

Revlimid Side Effects Report #5678331-7
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 17, 2008. Male patient, 80 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, non-hodgkin's lymphoma, rash , red blood cell count decreased. Revlimid dosage: 10 MG - 25 MG, QD, ORAL; 20 MG, X21 DAYS EVERY 28 DAYS, ORAL. Patient died on 02/07/2008.

Revlimid Side Effects Report #5162613-1
Revlimid side effect was reported by a Pharmacist from UNITED STATES on Nov 15, 2006. Male patient, 64 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, fluid overload, leukopenia, malignant neoplasm progression, metastases to lung, neutropenia, pleural effusion, pseudomonal sepsis, sarcoma. Revlimid dosage: 10 MG, DAILY DURING 21 DAYS CYCLE, ORAL. During the same period patient was treated with AVASTIN, TOPOTECAN, NEUPOGEN. Patient was hospitalized. Patient died on 05/26/2006.


Revlimid Side Effects Report #5400562-1
Revlimid side effect was reported by a Physician from SPAIN on July 18, 2007. Male patient, 52 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, non-hodgkin's lymphoma, pancytopenia. Revlimid dosage: 25 MG, EVERY DAY, DURING 21 DAYS, ORAL. Patient was hospitalized. Patient died on 07/17/2007.

Revlimid Side Effects Report #5193604-2
Revlimid side effect was reported by a Physician from CANADA on Dec 14, 2006. Male patient, 48 years of age, weighting 162.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Revlimid. After drug was administered, patient experienced the following side effects: anaemia, haemolytic anaemia, lymphoma , malignant neoplasm progression, pitting oedema, pyrexia, thrombocytopenia. Revlimid dosage: unknown. Patient was hospitalized. Patient died on 12/14/2006.

Revlimid Side Effects Report #5145544-2
Revlimid side effect was reported by a Pharmacist from UNITED STATES on Oct 24, 2006. Male patient, 25 years of age, was diagnosed with neoplasm malignant and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, malignant splenic neoplasm. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 10/19/2006.

Revlimid Side Effects Report #5148588-X
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 31, 2006. Female patient, 91 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: anaemia, dehydration, dysphagia, dyspnoea, fatigue, hip fracture, insomnia, malignant neoplasm progression, mental status changes. Revlimid dosage: 10 MG, DAILY FOR 21 DAYS, ORAL. During the same period patient was treated with ARICEPT, PEPCID, LEVAQUIN. Patient was hospitalized. Patient died on 05/01/2006.

Revlimid Side Effects Report #5374054-2
Revlimid side effect was reported by a Physician from UNITED STATES on June 19, 2007. Male patient, 84 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 05/31/2007.


Revlimid Side Effects Report #5657999-5
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 29, 2008. Male patient, 83 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 12/05/2007.

Revlimid Side Effects Report #5683220-8
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 19, 2008. Male patient, 83 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, malignant neoplasm progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 11/18/1923.

Revlimid Side Effects Report #5166101-8
Revlimid side effect was reported by a Physician from UNITED STATES on Nov 22, 2006. Female patient, 81 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, agranulocytosis, catheter related infection, malignant neoplasm progression, myelodysplastic syndrome, refusal of treatment by patient. Revlimid dosage: unknown. During the same period patient was treated with PEPCID, DIGOXIN, LORTAB, RESTORIL. Patient was hospitalized. Patient died on 08/01/2006.

Revlimid Side Effects Report #5797641-6
Revlimid side effect was reported by a Physician from UNITED STATES on June 24, 2008. Male patient, 80 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, malignant neoplasm progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 06/26/2007.

Revlimid Side Effects Report #5038105-7
Revlimid side effect was reported by a Physician from UNITED STATES on June 13, 2006. Male patient, 80 years of age, weighting 172.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: body temperature increased, leukaemia, malignant neoplasm progression. Revlimid dosage: 5 MG, QAM, ORAL. During the same period patient was treated with VERAPAMIL, DIGOXIN, PRIOSEL, PREDNISONE, AMICAR, PANCREASE. Patient was hospitalized. Patient died on 04/21/2006.


Revlimid Side Effects Report #5274750-1
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 12, 2007. Male patient, 79 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 01/09/2007.

Revlimid Side Effects Report #5348630-7
Revlimid side effect was reported by a Physician from UNITED STATES on May 29, 2007. Male patient, 79 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, full blood count decreased, haematocrit decreased, haemoglobin decreased, malignant neoplasm progression, platelet count decreased. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 04/20/2007.

Revlimid Side Effects Report #5194120-4
Revlimid side effect was reported by a Physician from UNITED STATES on Dec 12, 2006. Male patient, 79 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, myelodysplastic syndrome, thrombocytopenia, white blood cell count decreased. Revlimid dosage: unknown. Patient died on 11/17/2006.

Revlimid Side Effects Report #5721626-9
Revlimid side effect was reported by a Physician from AUSTRIA on Apr 15, 2008. Male patient, 79 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, prostate cancer recurrent. Revlimid dosage: unknown. Patient recovered.

Revlimid Side Effects Report #5680902-9
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 18, 2008. Female patient, 77 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression, myelodysplastic syndrome. Revlimid dosage: 10-5 MG, DAILY, ORAL, 10 MG, DAILY; ORAL. Patient died on 01/31/2008.


Revlimid Side Effects Report #5815638-4
Revlimid side effect was reported by a Physician from UNITED STATES on July 08, 2008. Male patient, 77 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: cardiac arrest , malignant neoplasm progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 01/01/2008.

Revlimid Side Effects Report #5699420-7
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 02, 2008. Male patient, 74 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, myelodysplastic syndrome, platelet count decreased, treatment noncompliance. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 08/18/2007.

Revlimid Side Effects Report #5490337-X
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 10, 2007. Female patient, 72 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, febrile neutropenia, malignant neoplasm progression, myelodysplastic syndrome, viral infection . Revlimid dosage: 5 MG, QOD, ORAL. Patient was hospitalized. Patient died on 12/29/2006.

Revlimid Side Effects Report #5371481-4
Revlimid side effect was reported by a Physician from UNITED STATES on June 18, 2007. Male patient, 71 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 03/21/2007.

Revlimid Side Effects Report #5417354-X
Revlimid side effect was reported by a Physician from UNITED STATES on Aug 07, 2007. Female patient, 71 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: fungal infection , hypotension, malignant neoplasm progression, myelodysplastic syndrome, neutropenic sepsis. Revlimid dosage: 10 MG, DAILY, ORAL. Patient was hospitalized. Patient died on 07/02/2007.


Revlimid Side Effects Report #5494033-4
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 16, 2007. Male patient, 70 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal haemorrhage, malignant neoplasm progression, mental status changes, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 08/31/2007.

Revlimid Side Effects Report #4998295-9
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 28, 2006. Male patient, 70 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression, renal failure. Revlimid dosage: 10 MG, DAILY, ORAL. Patient died on 03/19/2006.

Revlimid Side Effects Report #4998309-6
Revlimid side effect was reported by a Physician from UNITED STATES on May 02, 2006. Male patient, 70 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute lymphocytic leukaemia, malignant neoplasm progression, multi-organ failure, myelodysplastic syndrome. Revlimid dosage: 10 MG, DAILY, ORAL. Patient was hospitalized. Patient died on 03/31/2006.

Revlimid Side Effects Report #5144316-2
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 68 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 07/06/2006.

Revlimid Side Effects Report #5289471-9
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 26, 2007. Male patient, 68 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: anaemia, malignant neoplasm progression, myelodysplastic syndrome, prostate cancer . Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with TAXOTERE, LUPRON. Patient died on 01/06/2007.


Revlimid Side Effects Report #5366420-6
Revlimid side effect was reported by a Physician from UNITED STATES on June 12, 2007. Female patient, 68 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, haemorrhage intracranial, malignant neoplasm progression, refusal of treatment by patient. Revlimid dosage: unknown. During the same period patient was treated with DIOVAN, THYROID, ARANESP, NEULASTA, PRBC. Patient died.

Revlimid Side Effects Report #5144316-2
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 24, 2006. Female patient, 68 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 07/06/2006.

Revlimid Side Effects Report #5166100-6
Revlimid side effect was reported by a Physician from UNITED STATES on Nov 21, 2006. Male patient, 68 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: asthenia, diarrhoea, hypertension, malignant neoplasm progression, myelodysplastic syndrome. Revlimid dosage: 25 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 07/24/2006.

Revlimid Side Effects Report #5481051-5
Revlimid side effect was reported by a Physician from UNITED STATES on Sept 28, 2007. Female patient, 68 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with TRANSFUSION. Patient died on 07/06/2006.

Revlimid Side Effects Report #5294461-6
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 27, 2007. Male patient, 66 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: epistaxis, malignant neoplasm progression, myelodysplastic syndrome, renal impairment. Revlimid dosage: unknown. Patient was hospitalized. Patient died on 03/07/2007.


Revlimid Side Effects Report #5778886-8
Revlimid side effect was reported by a Physician from UNITED STATES on June 10, 2008. Male patient, 61 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, fungal infection , malignant neoplasm progression, myelodysplastic syndrome, nodule, pruritus, pyrexia, rash , white blood cell count decreased. Revlimid dosage: 15 MG, 1 IN 1 D, ORAL. During the same period patient was treated with POSACONAZOLE, VANCO, CASPOFUNGIN. Patient died on 05/14/2008.

Revlimid Side Effects Report #5242565-6
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 06, 2007. Male patient, 60 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died.

Revlimid Side Effects Report #5251972-7
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 13, 2007. Male patient, 57 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1D, ORAL. Patient died on 01/11/2007.

Revlimid Side Effects Report #5141691-X
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 19, 2006. Male patient, 57 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, malignant neoplasm progression. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 01/01/2006.

Revlimid Side Effects Report #5397058-2
Revlimid side effect was reported by a Physician from UNITED STATES on July 17, 2007. Female patient, 55 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, deep vein thrombosis , malignant neoplasm progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. During the same period patient was treated with DECITABINE. Patient was hospitalized. Patient died on 04/22/2007.

Revlimid Side Effects Report #5704635-5
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 02, 2008. Female patient, 52 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, intestinal obstruction, malignant neoplasm progression, myelodysplastic syndrome, respiratory failure, sepsis . Revlimid dosage: 20 MG, DAILY FOR 21 DAYS, ORAL. Patient died.

Revlimid Side Effects Report #5162620-9
Revlimid side effect was reported by a Physician from UNITED STATES on Nov 17, 2006. Female patient, 51 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, arthralgia, joint swelling, malignant neoplasm progression, nausea , night sweats, pruritus, pyrexia, urine output decreased. Revlimid dosage: 10 MG, QD, ORAL. Patient died.

Revlimid Side Effects Report #5483625-4
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 02, 2007. Male patient was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cerebral haemorrhage, malignant neoplasm progression. Revlimid dosage: 10 MG, 2 IN 1 D, ORAL. Patient died.

Revlimid Side Effects Report #6121045-X
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 13, 2009. Male patient was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Revlimid dosage: 5-10MG. Patient died on 12/11/2008.

Revlimid Side Effects Report #5761956-8
Revlimid side effect was reported by a Physician from UNITED STATES on May 28, 2008. Female patient, 93 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 15 MG, 1 IN 1 D, ORAL. Patient died on 03/21/2008.


Revlimid Side Effects Report #5778913-8
Revlimid side effect was reported by a Physician from UNITED STATES on June 10, 2008. Female patient, 93 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 15 MG, 1 IN 1 D, ORAL. Patient died on 03/21/2008.

Revlimid Side Effects Report #5778937-0
Revlimid side effect was reported by a Physician from UNITED STATES on June 10, 2008. Female patient, 93 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 15 MG, 1 IN 1 D, ORAL. Patient died on 03/21/2008.

Revlimid Side Effects Report #5512378-6
Revlimid side effect was reported by a Physician from UNITED STATES on Nov 02, 2007. Female patient, 92 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: abdominal pain , malignant neoplasm progression, multiple myeloma , nausea . Revlimid dosage: 25 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 07/30/2007.

Revlimid Side Effects Report #5211491-0
Revlimid side effect was reported by a Physician from UNITED STATES on Jan 08, 2007. Female patient, 88 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: confusional state, disorientation, hallucination, malignant neoplasm progression, multiple myeloma . Revlimid dosage: 25 MG, 1 IN 1 D, ORAL. During the same period patient was treated with DECADRON. Patient died on 01/05/2007.

Revlimid Side Effects Report #5692749-8
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 25, 2008. Female patient, 88 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 25 MG, 1 IN 1 D, ORAL. During the same period patient was treated with DILTIAZEM, POTASSIUM CHLORIDE, FERROUS SULPHATE, DECADRON, COMBIVENT. Patient died on 01/19/2008.

Revlimid Side Effects Report #5467637-2
Revlimid side effect was reported by a Physician from UNITED STATES on Sept 17, 2007. Female patient, 85 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: anaemia, malignant neoplasm progression, multiple myeloma , pyrexia, syncope. Revlimid dosage: 5 MG, X 28 DAYS, ORAL. Patient died on 06/11/2007.

Revlimid Side Effects Report #5200133-6
Revlimid side effect was reported by a Physician from UNITED STATES on Dec 27, 2006. Female patient, 83 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: amyloidosis, cardiac failure congestive, malignant neoplasm progression, multiple myeloma , nephrotic syndrome, renal failure chronic. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 09/10/2006.

Revlimid Side Effects Report #5315004-4
Revlimid side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 20, 2007. Male patient, 83 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , renal failure acute. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died.

Revlimid Side Effects Report #5331926-2
Revlimid side effect was reported by a Physician from UNITED STATES on May 11, 2007. Male patient, 83 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: kidney infection, malignant neoplasm progression, multiple myeloma , palpitations, pneumonia , renal failure. Revlimid dosage: 25 MG, DAILY FOR 21 DAYS WITH 7 DAYS OFF, ORAL. During the same period patient was treated with OXYCONTIN, LOPRESSOR, ALLOPURINOL, COLACE, FOLATE, LASIX, PHENOBARBITAL, PHENYTOIN. Patient died on 02/21/2007.

Revlimid Side Effects Report #5391026-2
Revlimid side effect was reported by a Physician from UNITED STATES on July 10, 2007. Female patient, 83 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 01/01/2007.


Revlimid Side Effects Report #5422053-4
Revlimid side effect was reported by a Physician from UNITED STATES on Aug 14, 2007. Female patient, 83 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , neutropenia, sepsis , thrombocytopenia. Revlimid dosage: 10 MG, DAILY, ORAL. During the same period patient was treated with VELCADE. Patient died on 06/26/2007.

Revlimid Side Effects Report #5423058-X
Revlimid side effect was reported by a Physician from UNITED STATES on Aug 14, 2007. Male patient, 83 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 25 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 07/12/2007.

Revlimid Side Effects Report #5463565-7
Revlimid side effect was reported by a Physician from UNITED STATES on Sept 11, 2007. Female patient, 83 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 05/02/2007.

Revlimid Side Effects Report #5637393-3
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 12, 2008. Female patient, 83 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 15 MG, QD X 21 AYS, ORAL. Patient died on 12/02/2007.

Revlimid Side Effects Report #5689360-1
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 24, 2008. Male patient, 83 years of age, weighting 135.0 lb, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 25 MG, ORAL. During the same period patient was treated with KEFLEX, DECADRON, LASIX, MIRALAX, TOPROL, POTASSIUM, ALTACE, SENOKOT. Patient died on 12/06/2007.

Revlimid Side Effects Report #5637393-3
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 12, 2008. Female patient, 83 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 15 MG, QD X 21 AYS, ORAL. Patient died on 12/02/2007.

Revlimid Side Effects Report #5692722-X
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 26, 2008. Female patient, 83 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died.

Revlimid Side Effects Report #5705149-9
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 02, 2008. Female patient, 83 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 01/01/2008.

Revlimid Side Effects Report #5765143-9
Revlimid side effect was reported by a Physician from UNITED STATES on May 28, 2008. Male patient, 83 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 25 MG, 1 IN 1 D, ORAL. During the same period patient was treated with AMBIEN, PROSCAR, PERCOCET, LORTAB, NORVASC, PROLIXIN, ZOCOR, TRICOR. Patient died on 05/28/2008.

Revlimid Side Effects Report #5787580-9
Revlimid side effect was reported by a Physician from UNITED STATES on June 16, 2008. Male patient, 83 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 25 MG, 1 IN 1 D, ORAL. During the same period patient was treated with AMBIEN, PROSCAR, PERCOCET, LORTAB, NORVASC, PROLIXIN, ZOCOR, TRICOR. Patient died on 05/28/2008.


Revlimid Side Effects Report #5836150-2
Revlimid side effect was reported by a Pharmacist from UNITED STATES on July 25, 2008. Male patient, 83 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: cachexia, malignant neoplasm progression, multiple myeloma . Revlimid dosage: 25 MG, ORAL. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5171581-8
Revlimid side effect was reported by a Physician from UNITED STATES on Nov 28, 2006. Female patient, 82 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 5 MG, QD X28 DAYS, ORAL. Patient died on 11/25/2006.

Revlimid Side Effects Report #5391029-8
Revlimid side effect was reported by a Physician from UNITED STATES on July 10, 2007. Female patient, 82 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: bone pain, conjunctivitis, dyspnoea, fatigue, malignant neoplasm progression, multiple myeloma , night sweats, periorbital oedema. Revlimid dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 04/12/2007.

Revlimid Side Effects Report #5430363-X
Revlimid side effect was reported by a Physician from UNITED STATES on Aug 22, 2007. Male patient, 82 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , sepsis . Revlimid dosage: 25 MG, DAILY X21 DAYS, ORAL. During the same period patient was treated with TOPAMAX. Patient died on 08/10/2007.

Revlimid Side Effects Report #5583420-1
Revlimid side effect was reported by a Physician from UNITED STATES on Dec 26, 2007. Female patient, 82 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malaise, malignant neoplasm progression, multiple myeloma , muscle spasms. Revlimid dosage: 25 MG, QD X14 DAYS, ORAL; 25 MG ORAL. Patient died on 04/12/2007.

Revlimid Side Effects Report #5615009-X
Revlimid side effect was reported by a Health Professional from UNITED STATES on Jan 28, 2008. Male patient, 82 years of age, was diagnosed with multiple myeloma , neoplasm and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , platelet count decreased. Revlimid dosage: 15 MG, 1 IN 1 D, ORAL, 10 MG, 1 IN 1 D, ORAL. Patient died on 01/15/2008.

Revlimid Side Effects Report #5761958-1
Revlimid side effect was reported by a Physician from UNITED STATES on May 27, 2008. Male patient, 82 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 25 MG, X21 DAYS EVERY 28 DAYS, ORAL; X21 DAYS EVERY 28 DAYS, ORAL. Patient died on 03/12/2008.

Revlimid Side Effects Report #5834781-7
Revlimid side effect was reported by a Physician from UNITED STATES on July 25, 2008. Male patient, 82 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: DAILY X21 DAYS, ORAL; 25MG - 15MG - 25MG, DAILY X21 DAYS, ORAL. Patient died on 05/27/2008.

Revlimid Side Effects Report #5382878-0
Revlimid side effect was reported by a Physician from UNITED STATES on June 29, 2007. Female patient, 81 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 15 MG, 1 IN 1 D, ORAL. Patient died on 11/27/2006.

Revlimid Side Effects Report #5293897-7
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 02, 2007. Male patient, 80 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , oedema peripheral, pain , pneumonia . Revlimid dosage: 15 MG, DAILY FOR 21 DAYS, ORAL. During the same period patient was treated with NEUPOGEN, MS CONTIN. Patient was hospitalized. Patient died on 03/04/2007.


Revlimid Side Effects Report #5388771-1
Revlimid side effect was reported by a Physician from UNITED STATES on July 06, 2007. Male patient, 80 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , orthostatic hypotension, presyncope. Revlimid dosage: unknown. Patient was hospitalized. Patient died on 05/21/2007.

Revlimid Side Effects Report #5637183-1
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 15, 2008. Male patient, 80 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, QD, ORAL. Patient died on 05/31/2007.

Revlimid Side Effects Report #5675869-3
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 12, 2008. Male patient, 80 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 01/26/2008.

Revlimid Side Effects Report #5704652-5
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 02, 2008. Male patient, 80 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 10 MG, QD, ORAL. During the same period patient was treated with SYNTHROID, DARVOCET, APAP, NEURONTIN, LYRICA. Patient died on 05/31/2007.

Revlimid Side Effects Report #5712362-3
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 11, 2008. Female patient, 80 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 25 MG, DAILY X21 DAYS, ORAL. Patient died.

Revlimid Side Effects Report #5787988-1
Revlimid side effect was reported by a Physician from UNITED STATES on June 17, 2008. Male patient, 80 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 15 MG, 1 IN 1 D, ORAL. Patient died on 04/13/2008.

Revlimid Side Effects Report #5242538-3
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 06, 2007. Female patient, 79 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 20 MG, 2 IN 1 D, ORAL. Patient died.

Revlimid Side Effects Report #5268595-6
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 07, 2007. Male patient, 79 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 25 MG, 1 IN 1 D, ORAL. Patient died.

Revlimid Side Effects Report #5293138-0
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 27, 2007. Male patient, 79 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multi-organ failure, multiple myeloma . Revlimid dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 02/14/2007.

Revlimid Side Effects Report #5308362-8
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 13, 2007. Male patient, 79 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , respiratory failure. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 10/18/2006.

Revlimid Side Effects Report #5365846-4
Revlimid side effect was reported by a Physician from UNITED STATES on June 12, 2007. Male patient, 79 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, malignant neoplasm progression, multi-organ failure, multiple myeloma . Revlimid dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 02/14/2007.

Revlimid Side Effects Report #5144315-0
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 23, 2006. Male patient, 79 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: bone marrow failure, malignant neoplasm progression, multiple myeloma . Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. During the same period patient was treated with ARANESP. Patient died on 08/02/2006.

Revlimid Side Effects Report #5691464-4
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 26, 2008. Female patient, 79 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: unknown. Patient was hospitalized. Patient died on 02/07/2008.

Revlimid Side Effects Report #5778851-0
Revlimid side effect was reported by a Physician from UNITED STATES on June 09, 2008. Female patient, 79 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: hypercalcaemia, malignant neoplasm progression, multiple myeloma . Revlimid dosage: 10 MG, DAILY FOR 21 DAYS, ORAL. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5820161-7
Revlimid side effect was reported by a Physician from UNITED STATES on July 15, 2008. Female patient, 79 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: haematotoxicity, malignant neoplasm progression, multiple myeloma . Revlimid dosage: 25 MG, ORAL. Patient died on 05/06/2008.

Revlimid Side Effects Report #5840393-1
Revlimid side effect was reported by a Physician from UNITED STATES on Aug 01, 2008. Male patient, 79 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: infection , malignant neoplasm progression, multiple myeloma . Revlimid dosage: 10 MG, DAYS 1-21, ORAL; 25 MG, 1 IN 1 D, ORAL. Patient died on 06/03/2008.

Revlimid Side Effects Report #5033197-3
Revlimid side effect was reported by a Health Professional from UNITED STATES on June 07, 2006. Female patient, 79 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: anaemia, coordination abnormal, malignant neoplasm progression, multiple myeloma , renal failure acute, septic shock. Revlimid dosage: 10 MG, QD, ORAL. Patient died on 06/01/2006.

Revlimid Side Effects Report #5044212-5
Revlimid side effect was reported by a Pharmacist from UNITED STATES on June 16, 2006. Female patient, 79 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: anaemia, coordination abnormal, diverticulitis, fatigue, malignant neoplasm progression, multiple myeloma , renal failure acute, septic shock. Revlimid dosage: unknown. Patient was hospitalized. Patient died on 06/01/2006.

Revlimid Side Effects Report #5282520-3
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 20, 2007. Male patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 25 MG, DAILY, ORAL. Patient died on 01/12/2007.

Revlimid Side Effects Report #5509320-0
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 30, 2007. Female patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 10 MG-20 MG, DAILY, ORAL; 10 MG, 1 IN 1 D, ORAL. Patient died on 09/12/2007.

Revlimid Side Effects Report #5530006-0
Revlimid side effect was reported by a Physician from UNITED STATES on Nov 20, 2007. Male patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: anorexia, deep vein thrombosis , dehydration, fatigue, haematuria, haemodialysis, hyperkalaemia, malignant neoplasm progression, multiple myeloma . Revlimid dosage: 20 MG, 2 IN 1 D, ORAL. During the same period patient was treated with PAMIDRONATE DI, ALLOPURINOL, DECADRON, PRILOSEC, VITAMIN, ASPIRIN, PERCOCET, FENTANYL. Patient was hospitalized. Patient died on 11/01/2007.

Revlimid Side Effects Report #5741041-1
Revlimid side effect was reported by a Physician from UNITED STATES on May 08, 2008. Male patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: constipation , dizziness , dyspnoea, malignant neoplasm progression, mental disorder, multiple myeloma , muscular weakness, neuropathy peripheral. Revlimid dosage: unknown. Patient died on 03/23/2008.

Revlimid Side Effects Report #5837768-3
Revlimid side effect was reported by a Physician from UNITED STATES on July 31, 2008. Female patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, fall , malignant neoplasm progression, mental status changes, multiple myeloma , pancytopenia. Revlimid dosage: 10 MG, TIW (M, W, F) AFTER DIALYSIS, ORAL 5 MG, ORAL. During the same period patient was treated with DECADRON, VICODIN, FENTANYL, MEGESTROL ACETATE, ZOLPIDEM TARTRATE, FLUTICASONE PROPIONATE, METOPROLOL TARTRATE. Patient was hospitalized. Patient died on 06/05/2008.

Revlimid Side Effects Report #5039831-6
Revlimid side effect was reported by a Consumer or non-health professional from UNITED STATES on June 14, 2006. Male patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma . Revlimid dosage: 5 MG, DAILY, ORAL. Patient died on 05/31/2006.